We are live on
!
Find out more
DI
DAGCO Inc Portfolio holdings
AUM
$541M
1-Year Est. Return
29.31%
This Fund
S&P 500
This Quarter
Est. Return
+1.69%
1 Year Est. Return
+29.31%
3 Year Est. Return
+66.54%
5 Year Est. Return
+76.11%
10 Year Est. Return
–
AUM
$225M
AUM Growth
+$5.73M
(+2.6%)
Cap. Flow
+$3.16M
Cap. Flow
% of AUM
1.4%
Top 10 Holdings %
Top 10 Hldgs %
53.67%
Holding
232
New
13
Increased
59
Reduced
47
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Travelers Companies
TRV
|
+$1.39M |
| 2 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$731K |
| 3 |
Salesforce
CRM
|
+$671K |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$278K |
| 5 |
Invesco QQQ Trust
QQQ
|
+$247K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$193K |
| 2 |
iShares Core Dividend Growth ETF
DGRO
|
+$161K |
| 3 |
Vanguard Morningstar Growth ETF
VUG
|
+$143K |
| 4 |
NextEra Energy
NEE
|
+$135K |
| 5 |
Nike
NKE
|
+$95.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.72% |
| 2 | Financials | 5.5% |
| 3 | Healthcare | 4.53% |
| 4 | Industrials | 4.21% |
| 5 | Communication Services | 2.44% |
Similar funds
CIAM
FMC
BCB
MAM
FF
PHC
WCA
HCM
DAGCO Inc's Q2 2024 Portfolio in Review
As of Q2 2024, DAGCO Inc held 232 positions worth $225M, up 2.6% from $220M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
DAGCO Inc's Q2 2024 filing shows 13 new, 59 increased, 47 reduced and 13 closed positions. Its largest new stake was Travelers Companies: 6,467 shares worth $1.32M. The largest sale was Bristol-Myers Squibb, an estimated $193K.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.6% a quarter earlier, followed by Financials and Healthcare.
- DAGCO Inc's largest Q2 2024 buy was Travelers Companies: 6,467 shares worth $1.32M.
- DAGCO Inc added most to State Street SPDR Portfolio Short Term Treasury ETF in Q2 2024, an estimated $731K increase.
- DAGCO Inc's biggest Q2 2024 reduction was iShares Core Dividend Growth ETF, cutting an estimated $161K.
- DAGCO Inc fully exited Bristol-Myers Squibb in Q2 2024, selling an estimated $193K.
- DAGCO Inc's ten largest holdings make up 54% of its $225M portfolio in Q2 2024.
- DAGCO Inc opened 13 new positions and closed 13 in Q2 2024.
- DAGCO Inc's portfolio value rose 2.6% quarter-over-quarter to $225M.
Based on DAGCO Inc's 13F filing for Q2 2024, filed 14 Aug 2024.